CompoAtlas

SGVG CHITOSAN 350MG CAPSULE

SGVG CHITOSAN 350MG CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL20000420X
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Manufacturer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Registration period starting
2025-04-09
Published validity end
2030-04-09

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
CHITOSANCHITOSAN[350MG]Chitosan

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
CHITOSAN[350MG]
Valid until
2030-04-09
Registration date
2025-04-09
Published description
HEALTH SUPPLEMENT
Licence holder
WHITE HERON PHARMACEUTICAL SDN. BHD.
Producer
WHITE HERON PHARMACEUTICAL SDN. BHD.
Published name
SGVG CHITOSAN 350MG CAPSULE
Published reference
1999113746X
Registration number
MAL20000420X
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20000420X

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • CHITOSAN
    Read the warning, when it applies and the studies cited

    CHITOSAN

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Pittler et al. 1999).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products (except for weight management).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Weight management.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Condition of application: All products.

    Do not use if you have an allergy to seafood.

    Condition of application: Weight management.

    Do not use if you are pregnant (HC 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moraru et al. 2018; Mhurchu et al. 2004; Pittler et al. 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line